Tag Archives: Lp(a) Test

Roche and Amgen Collaborate on Breakthrough Lp(a) Test for Cardiovascular Disease Risk

(IN BRIEF) Roche Diagnostics has announced that its Tina-quant® lipoprotein Lp(a) RxDx assay has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA). Developed in collaboration with Amgen, this innovative test aims to identify individuals at risk … Read the full press release